AIkenist's Product Videos
Compete with AIkenist?
Ensure that your company and products are accurately represented on our platform.
AIkenist's Products & Differentiators
QuickScan accelerates MRI scanning by 2x which means 20 mins scan can take 10 mins now. The solution enhances patient convenience and improves return on investment for hospitals and diagnostic centres. The solution is based on very innovative technology using AI-based algorithms
Expert Collections containing AIkenist
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
AIkenist is included in 3 Expert Collections, including Medical Devices.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Latest AIkenist News
May 7, 2020
Bengaluru-based AIkenist is looking to solve the coronavirus problem through its artificial intelligence tool, which distinguishes COVID-19 related pneumonia by analysing lung damage in the patients. Share on The coronavirus pandemic has posed to be one of the greatest healthcare challenges before the world. While countries across the world have stepped up efforts to carefully screen patients to avoid the spread of the coronavirus, the burden ultimately rests on the shoulders of healthcare professionals, who are risking their own lives to save others. In India, which has a population of 1.3 billion, pre-screening the public before they go for COVID-19 tests might be a good option to reduce the load on our healthcare professionals and resources. Keeping this in mind, Bengaluru-based AIkenist has come up with an artificial intelligence (AI) tool, which distinguishes COVID-19 related pneumonia depending on the patient’s lung damage. Ashwin Amarapur, Founder and CEO, AIkenist The startup was founded in 2019 by Ashwin Amarapur. It provides AI-based solutions for faster scanning and better detection, with quick turnaround solutions for healthcare problems. Speaking to YourStory, Ashwin Amarapur, Founder and CEO, AIkenist, explains, the company has developed a cloud-hosted AI solution called AIkenist QuickDiag COVID 19, which is compatible with all kinds of digital X-ray and CT scanning machines. The chest X-ray and CT-scan images are pushed to the cloud service where lung anomaly is diagnosed to screen COVID-19 patients. Apart from this, the company currently offers an AI-based product called Quickscan for MRI scans, and claims it diagnoses the issue four times faster. Its other product, Quickdiag, provides AI-analysis for tumor detection and segmentation of brain, liver, pancreas, etc. AI-based radiology solution “We have developed a solution which actually detects the extent of damage inside the lungs. We can detect bilobular anomaly, opacities, and consolidation in a patient who might be infected with coronavirus,” says Ashwin. According to him, the cloud software analyses the images and shares the results with healthcare professionals to help them decide the next course of action. He also claims the results are available within a minute after the scans are uploaded in the server. Ashwin says, the startup is also looking to make the solution affordable to the masses, and will cost around Rs 100 per scan. Current status In April this year, AIkenist was nominated by Bengaluru-based incubator Centre for Cellular and Molecular Platforms (C-CAMP) as a deployment-ready COVID-19 innovation. According to Ashwin, the company developed the solution after studying data sets across countries. “We have got datasets from different hospitals from China, Italy, the UK and other European countries, and we are actually working on data collection in India, and thus it is an ongoing effort. We are also working with C-CAMP to propose hospitals for deployment.” Ashwin explains the company is planning to complete its clinical trials and get the product out in the market for use within a month’s time. “We are looking at Victoria Hospital in Bengaluru and SevenHills hospital in Mumbai for trials and deployment,” Ashwin says. Speaking about future plans, Ashwin says, the company is now looking to complete its one-month trials and try the solution in at least 10 hospitals. Following this, the company is looking at a wider deployment of the solution. At present, the total number of Covid-19 cases in India have crossed the 46,000-mark, as per the latest update by the Union Health Ministry. Over 1,500 people have died due to the virus across the country. How has the coronavirus outbreak disrupted your life? And how are you dealing with it? Write to us or send us a video with subject line 'Coronavirus Disruption' to firstname.lastname@example.org
AIkenist Web Traffic
AIkenist Frequently Asked Questions (FAQ)
Where is AIkenist's headquarters?
AIkenist's headquarters is located at #1,1st Floor, Bengaluru.
What is AIkenist's latest funding round?
AIkenist's latest funding round is Incubator/Accelerator.
Who are the investors of AIkenist?
Investors of AIkenist include C-CIDA.
What products does AIkenist offer?
AIkenist's products include QuickScan and 1 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.